IMMUNE CHECKPOINT INHIBITORS
Clinical trials for IMMUNE CHECKPOINT INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study reveals why immunotherapy works differently in liver, lung, and brain tumors
Knowledge-focused CompletedThis study looked at medical records of 938 adults with solid tumors who received immunotherapy. Researchers compared how well the treatment worked when cancer had spread to different organs like the liver, brain, lung, or bone. The goal is to understand why some metastatic sites…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: Wenlong Zhong, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Your feelings and blood work could predict cancer treatment outcomes
Knowledge-focused CompletedThis study followed 196 people with advanced lung or stomach cancer who had not yet received treatment. Researchers wanted to see if emotional distress before starting immunotherapy, along with certain blood markers of inflammation and metabolism, could predict how long patients …
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC